Outcome Capital, a highly specialised life sciences and healthcare advisory and investment banking firm, has appointed Karl Hess as Managing Director in its Boston office.
Hess will lead the firm’s HealthTech and Digital Health segment, a rapidly growing practice area that is benefiting from Outcome’s 20-plus year track record of successful transactions and managed transformation opportunities for its life sciences clients.
Hess was most recently Interim President and CEO of Texas Health Aetna, a health innovation company created by Texas Health Resources and Aetna, a CVS Health Company.
